Creatinine Clearance vs eGFR
Cockcroft–Gault creatinine clearance and a laboratory-reported eGFR answer different questions with different equations — substituting one for the other can change a dosing decision.
Two different quantities, often confused
Cockcroft–Gault remains the reference equation for renal dose adjustment because the pharmacokinetic studies underpinning FDA labelling used it. It is not the same as an eGFR reported by the laboratory, which uses CKD-EPI and is normalised to 1.73 m². When a package insert specifies a creatinine clearance threshold, it means this equation.
Cockcroft–Gault estimates creatinine clearance in mL/min. A laboratory-reported eGFR is a different quantity, uses a different equation, and is normalised to 1.73 m² of body surface area. Do not substitute one for the other when a package insert specifies a CrCl threshold.
Why the distinction changes a dose
An eGFR is normalised to a standard 1.73 m² body surface area, which makes it a useful population screening figure but not the number a drug label’s renal-adjustment threshold was built around. When a package insert specifies a creatinine clearance cutoff, it means the un-normalised Cockcroft–Gault result — the equation used in the pharmacokinetic studies behind that labelling — not the CKD-EPI eGFR a laboratory report shows next to a serum creatinine.
Where Cockcroft–Gault itself becomes unreliable
- Derived in 1976 from 249 hospitalised men. Female patients are represented only by an applied 0.85 factor, not by independent derivation.
- Invalid in unstable or rapidly changing renal function, including acute kidney injury and the immediate post-dialysis period.
- Unreliable at the extremes of body habitus. In obesity, total body weight substantially overestimates clearance; the choice of weight can change the answer by a factor of two.
- Not validated in children, in pregnancy, or in patients on renal replacement therapy.
- Estimates creatinine clearance, which itself overestimates true glomerular filtration rate because creatinine is secreted as well as filtered.
A related but distinct question: is the patient volume-depleted?
Urea is reabsorbed with sodium and water in the proximal tubule while creatinine is not, so in volume depletion urea rises disproportionately. A ratio above roughly 20:1 supports a prerenal picture, whereas an intrinsic renal injury typically keeps the ratio nearer 10–15:1.
The ratio is least useful in the very patients where volume status is hardest to judge — those with cirrhosis, heart failure, or on diuretics.
Practical takeaway
Use the equation the reference you are following actually specifies. If a package insert or guideline gives a creatinine clearance threshold in mL/min, calculate Cockcroft–Gault rather than reading the laboratory’s eGFR off the same report — the two numbers can differ enough to change which side of a dosing threshold a patient falls on.
References
- Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
- US Food and Drug Administration. Guidance for Industry: Pharmacokinetics in Patients with Impaired Renal Function — Study Design, Data Analysis, and Impact on Dosing. link
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314.
- Winter MA, et al. Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation. Pharmacotherapy. 2012;32(7):604-612.
- Rachoin JS, et al. The fallacy of the BUN:creatinine ratio in critically ill patients. Nephrol Dial Transplant. 2012;27(6):2248-2254.
- Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2:1-138.